Inovio Pharma Articles
Biotron shares leap 29% on hepatitis C Ph IIa positive results; Inovio advances hepatitis vaccines
11 October 2011
Showing 1-3 of 3 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
